2023
DOI: 10.1007/s10388-023-00993-2
|View full text |Cite
|
Sign up to set email alerts
|

Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
33
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 102 publications
(53 citation statements)
references
References 167 publications
(235 reference statements)
0
33
0
Order By: Relevance
“…For whole circumferential lesions longer than 5 cm, the Japanese guidelines recommended surgery, chemoradiotherapy or radiotherapy. 6,8 Another indication for surgery would be the recurrent neoplasm adjacent to or at the site of previous endoscopic treatment. In such cases, repeat endoscopic treatment would be technically demanding as the submucosal layers will have extensive scarring.…”
Section: Indications For Surgerymentioning
confidence: 99%
“…For whole circumferential lesions longer than 5 cm, the Japanese guidelines recommended surgery, chemoradiotherapy or radiotherapy. 6,8 Another indication for surgery would be the recurrent neoplasm adjacent to or at the site of previous endoscopic treatment. In such cases, repeat endoscopic treatment would be technically demanding as the submucosal layers will have extensive scarring.…”
Section: Indications For Surgerymentioning
confidence: 99%
“…Therefore, the standard treatment for this cancer is surgery or irradiation 2 ; however, these treatments have a disadvantage of over‐invasiveness. Currently, endoscopic submucosal dissection (ESD) is a standard treatment for SEC because of its minimal invasiveness and good effectiveness 3 . ESD for SEC in a diverticulum is challenging for endoscopists, and the indication of ESD should be determined with caution.…”
Section: Introductionmentioning
confidence: 99%
“…Squamous cell carcinoma is the predominant type of esophageal cancer in Asia 2 . Endoscopic resection (is a curative treatment for esophageal cancers with negligible risk of metastasis, 3 while additional treatment after endoscopic resection is recommended for cancers with a substantial risk of metastasis based on a pathological assessment of resected specimens 4,5 …”
Section: Introductionmentioning
confidence: 99%
“…Esophagectomy and chemoradiotherapy are the leading options for adjuvant therapy for esophageal squamous cell carcinoma after endoscopic resection 4,5 . The extent of lymphadenectomy during esophagectomy and the radiation field in chemoradiotherapy are determined based on the subsite of the original esophageal squamous cell carcinoma, such as the cervical esophagus, upper thoracic esophagus, middle thoracic esophagus, or lower thoracic esophagus 5–8 .…”
Section: Introductionmentioning
confidence: 99%